Dextenza intraocular and Lenvatinib Mesylate
Determining the interaction of Dextenza intraocular and Lenvatinib Mesylate and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: dexamethasone ophthalmic
Brand name: Dextenza, Dexycu, Ozurdex, Maxidex
Synonyms: Dextenza (intraocular), Dextenza Insert
Generic Name: lenvatinib
Brand name: Lenvima, Lenvima 8 mg daily-dose, Lenvima 20 mg daily-dose, Lenvima 12 mg daily-dose
Synonyms: Lenvatinib
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Dextenza intraocular-Lenvima
- Dextenza intraocular-Lenvima (14 MG Daily Dose)
- Dextenza intraocular-Lenvima (18 MG Daily Dose)
- Dextenza intraocular-Lenvima (20 MG Daily Dose)
- Dextenza intraocular-Lenvima (24 MG Daily Dose)
- Dextenza intraocular-Lenvima (8 MG Daily Dose)
- Lenvatinib Mesylate-Dextran 40
- Lenvatinib Mesylate-Dextran 70 6% in 5% Dextrose high molecular weight
- Lenvatinib Mesylate-Dextran 75
- Lenvatinib Mesylate-Dextran high molecular weight
- Lenvatinib Mesylate-Dextranomer and Hyaluronate Derivatives (Deflux)
- Lenvatinib Mesylate-Dextranomer and Hyaluronate Derivatives (Solesta)